INVO Fertility, Inc. Files 8-K with Material Agreement
Ticker: IVF · Form: 8-K · Filed: Oct 3, 2025 · CIK: 1417926
Sentiment: neutral
Topics: material-agreement, equity-sale, corporate-action
TL;DR
INVO Fertility (IVOF) filed an 8-K on 9/30/25, reporting a material agreement and equity sales. Formerly NAYA Biosciences.
AI Summary
On September 30, 2025, INVO Fertility, Inc. entered into a Material Definitive Agreement. The company also reported on Unregistered Sales of Equity Securities and filed Financial Statements and Exhibits. INVO Fertility, Inc. was formerly known as NAYA Biosciences, Inc. until October 22, 2024.
Why It Matters
This 8-K filing indicates significant corporate activity, including a new material agreement and potential equity transactions, which could impact the company's future operations and financial standing.
Risk Assessment
Risk Level: medium — The filing mentions unregistered sales of equity securities and a material definitive agreement, which can introduce financial and operational risks.
Key Players & Entities
- INVO Fertility, Inc. (company) — Registrant
- NAYA Biosciences, Inc. (company) — Former company name
- September 30, 2025 (date) — Date of earliest event reported
- October 22, 2024 (date) — Date of name change from NAYA Biosciences, Inc.
FAQ
What is the nature of the Material Definitive Agreement entered into by INVO Fertility, Inc. on September 30, 2025?
The filing does not specify the details of the Material Definitive Agreement, only that one was entered into on September 30, 2025.
What type of equity securities were sold in the unregistered sales reported by INVO Fertility, Inc.?
The filing mentions 'Unregistered Sales of Equity Securities' but does not provide specific details about the type or amount of securities sold.
When did INVO Fertility, Inc. change its name from NAYA Biosciences, Inc.?
INVO Fertility, Inc. changed its name from NAYA Biosciences, Inc. on October 22, 2024.
What is the state of incorporation for INVO Fertility, Inc.?
INVO Fertility, Inc. is incorporated in Nevada.
What are the main items reported in this 8-K filing by INVO Fertility, Inc.?
This 8-K filing reports on an Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, and Financial Statements and Exhibits.
Filing Stats: 1,105 words · 4 min read · ~4 pages · Grade level 11 · Accepted 2025-10-03 16:05:56
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value IVF The Nasdaq Stock Mark
- $6,010,000 — s that Wood Violet would pay Dr. Pritts $6,010,000 in full and final settlement and satisf
- $1 million — nder the WFI Documents. Of this amount, $1 million has been paid as of the date hereof, an
- $755,000 — nd the remainder is payable as follows: $755,000 due September 30, 2025, $755,000 due De
- $1,000,000 — , 2025, $755,000 due December 31, 2025, $1,000,000 due March 31, 2026, $2,000,000 due June
- $2,000,000 — 1, 2025, $1,000,000 due March 31, 2026, $2,000,000 due June 30, 2026, and $500,000 due Dec
- $500,000 — 2026, $2,000,000 due June 30, 2026, and $500,000 due December 31, 2026. The Company agre
- $400,000 — rred, with an aggregate stated value of $400,000, for $400,000 in cash. As a result of t
- $0.7141 — price on the C-2 Preferred adjusted to $0.7141 per share. The C-2 Preferred issued pur
Filing Documents
- form8-k.htm (8-K) — 43KB
- ex10-1.htm (EX-10.1) — 82KB
- 0001493152-25-016850.txt ( ) — 303KB
- ivf-20250930.xsd (EX-101.SCH) — 3KB
- ivf-20250930_lab.xml (EX-101.LAB) — 33KB
- ivf-20250930_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 3, 2025 INVO FERTILITY, INC. /s/ Steven Shum Steven Shum Chief Executive Officer